CLSN


Celsion Corporation (CLSN) Shares on the Rise; Here’s Why

Celsion Corporation (NASDAQ:CLSN) investors have a smile on their faces Thursday morning, after the tiny drug maker won FDA clearance for OVATION II Study, …

The Good and the Ugly Side of Biotech: Celsion Corporation (CLSN), Cytokinetics, Inc. (CYTK)

The Good: Oppenheimer Sees Celsion Corporation Shares Soaring About 180% Over 12 Months It can be tricky putting a price tag on a …

Celsion Corporation (CLSN) Shares Climb on Back of New Findings in Liver Tumours Study

Today, shareholders of Celsion Corporation (NASDAQ:CLSN) woke up to a nice 5% pop in the value of their shares, after the drug maker announced …

Celsion Corporation (CLSN) Spooks Investors with a Share Dilution

Shares of Celsion Corporation (NASDAQ:CLSN) dived nearly 20% in morning trade Friday, after the drug maker’s stock offering priced at a deep discount. The …

Company Update (NASDAQ:CLSN): Celsion Corporation Announces Publication of the HEAT Study Manuscript in Clinical Cancer Research Journal 

Celsion Corporation (NASDAQ:CLSN) announced publication of the manuscript, “Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable …

Company Update (NASDAQ:CLSN): Celsion Corporation to Host R&D Day After Market Close

Celsion Corporation (NASDAQ:CLSN) announced that it will host a Research and Development (R&D) Day for investors and analysts on Thursday, October 12, 2017.  …

Celsion Corporation’s (CLSN) a Street Rocket Again

Celsion Corporation (NASDAQ:CLSN) shareholders are stoked in anticipation for tomorrow’s R&D Day conference set in New York City, with shares experiencing a just …